Regression of Kaposi’s sarcoma during therapy with HIV-1 protease inhibitors: A prospective pilot study
- 1 April 1998
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 38 (4) , 594-598
- https://doi.org/10.1016/s0190-9622(98)70124-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Resolution of Kaposi’s sarcoma associated with undetectable level of human herpesvirus 8 DNA in a patient with AIDS after protease inhibitor therapyJournal of the American Academy of Dermatology, 1997
- Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral TherapyNew England Journal of Medicine, 1997
- Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)Proceedings of the National Academy of Sciences, 1996
- Kaposi's sarcoma: Advances and perspectivesJournal of the American Academy of Dermatology, 1996
- Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and ZalcitabineNew England Journal of Medicine, 1996
- Treatment of Kaposi's SarcomaArchives of Dermatology, 1996
- Herpesvirus-Like DNA Sequence in Angiosarcoma in a Patient without HIV InfectionNew England Journal of Medicine, 1996
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994
- Systemic treatment of Kaposiʼs sarcomaAIDS, 1994
- Does Regressed Posttransplantation Kaposi’s Sarcoma Recur following Reintroduction of Immunosuppression?American Journal of Nephrology, 1992